scispace - formally typeset
R

Rainer J. Klement

Researcher at University of Zurich

Publications -  141
Citations -  4144

Rainer J. Klement is an academic researcher from University of Zurich. The author has contributed to research in topics: Medicine & Stars. The author has an hindex of 30, co-authored 117 publications receiving 3405 citations. Previous affiliations of Rainer J. Klement include University of Würzburg & Max Planck Society.

Papers
More filters
Journal ArticleDOI

The risk‐benefit ratio of Covid‐19 vaccines: Publication policy by retraction does nothing to improve it

TL;DR: A risk benefit analysis of COVID-19 vaccines was published by as mentioned in this paper , which showed that very likely for three deaths prevented by vaccination, about two people die as a consequence of these vaccinations.
Journal ArticleDOI

The inflammation paradox: Why are Tsimane protected against Western diseases while Westerners are not?

TL;DR: Two field studies with Westerners who returned to a simulated Palaeolithic lifestyle in a National park for 4 days and detected elevated inflammation markers, analogous to the conditions of the Tsimane are carried out, proposing three hypotheses for this inflammatory paradox.
Journal ArticleDOI

Addressing the controversial role of ketogenic diets in cancer treatment.

TL;DR: Skepticism about using KDs during cancer treatment is discussed and further steps needed to gain better evidence about the KD’s antitumor effect hypothesis are identified.
Journal ArticleDOI

Classification of field dwarfs and giants in RAVE and its use in stellar stream detection

TL;DR: In this paper, the authors used the available spectroscopic log g estimates from the second RAVE data release (DR2) to assign each star a probability for being a dwarf or subgiant/giant based on mixture model fits to the log g distribution in different color bins.
Journal ArticleDOI

Comment to Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease; an individual patient data analysis of three clinical trials.

TL;DR: It is concluded that in T1-2 N1 breast cancer patients who have received modern chemotherapy drugs PMRT does not provide any benefit for overall and disease-free survival.